EBV-lymphoma treatments on the horizon
Published 2020-12-08
Epstein–Barr virus (EBV)-related lymphomas are a heterogeneous group of hematologic malignancies that all harbor latent EBV within tumor cells. Pierluigi Porcu, MD, Sidney Kimmel Cancer Center, Philadelphia, PA, talks on what we can look forward to in terms of treatment for EBV-lymphomas in 2021, highlighting the use of CAR-T. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.
